Article | April 28, 2026

Embedded AI Is The Future Of Biopharmaceutical Recipe Creation

Source: Emerson
AI, artificial intelligence, medicine technology, digital transformation-GettyImages-2276984949

An MES and a DCS are built and run very differently. A DCS often leans on predetermined control logic, while an MES encodes the workflows and rules of each organization. Experienced engineers are harder to find for both, so recipe creation has to take less manual effort. Most AI recipe tools were designed for simple MES environments and small-scale R&D. They struggle once a program moves to large-scale manufacturing under full GMP. Emerson's Kristel Biehler, writing in Control Engineering, argues that AI built into the automation architecture scales further than AI added on top. Embedded tools can draw on decades of institutional knowledge and on data that external software cannot reach. See how her case holds up.

Access The Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online